FORSIGHT VISION5
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently in its second Phase 2 clinical study for its lead product, the Helios insert.
FORSIGHT VISION5
Social Links:
Industry:
Health Care Incubators Medical Pharmaceutical
Founded:
2010-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.forsightvision5.com
Total Employee:
11+
Status:
Active
Contact:
(650)325-2050
Email Addresses:
[email protected]
Total Funding:
59.6 M USD
Technology used in webpage:
Google Font API Google Maps GStatic Google Static Content Google Maps API Akamai Hosted MarkMonitor DNS
Similar Organizations
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
LENZ Therapeutics
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morgenthaler Ventures
Morgenthaler Ventures investment in Series C - ForSight VISION5
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series C - ForSight VISION5
Versant Ventures
Versant Ventures investment in Series C - ForSight VISION5
Delphi Ventures
Delphi Ventures investment in Series C - ForSight VISION5
Technology Partners
Technology Partners investment in Series C - ForSight VISION5
Technology Partners
Technology Partners investment in Series B - ForSight VISION5
Delphi Ventures
Delphi Ventures investment in Series B - ForSight VISION5
Versant Ventures
Versant Ventures investment in Venture Round - ForSight VISION5
Morgenthaler Ventures
Morgenthaler Ventures investment in Venture Round - ForSight VISION5
Split Rock Partners
Split Rock Partners investment in Venture Round - ForSight VISION5
Official Site Inspections
http://www.forsightvision5.com
- Host name: 204.74.99.105
- IP address: 204.74.99.105
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ForSight VISION5"
ForSight VISION5 - Crunchbase Company Profile & Funding
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace …See details»
ForSight VISION5 (now Allergan) - LinkedIn
ForSight VISION5 (now Allergan) | 195 followers on LinkedIn. ForSight VISION5 was acquired by Allergan in 2016. | ForSight VISION5 is focused on developing non-invasive products that replace eye ...See details»
ForSight VISION5 2025 Company Profile: Valuation, Investors ...
ForSight VISION5 General Information Description. Developer of drug delivery technologies for the treatment of eye vision. The company focuses on developing non-invasive products that …See details»
Allergan to Acquire Eye Care Company ForSight VISION5 Adding …
Aug 11, 2016 DUBLIN and MENLO PARK, Calif., Aug. 11, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and ForSight VISION5, a privately …See details»
ForSight VISION5 (now Allergan) Overview - SignalHire
Organization Website. forsightvision5.com . Social Links. Phone Number (650)325-2050. ForSight VISION5 (no... industries. Pharma Headquarters Location. 191 Jefferson Dr, Menlo Park, CA, …See details»
Allergan to Acquire Eye Care Company ForSight VISION5
Aug 11, 2016 Allergan and ForSight VISION5, a privately held, clinical-stage biotechnology company focused on eye care, have entered into an agreement under which Allergan will …See details»
Allergan to Acquire Eye Care Company ForSight VISION5 Adding …
Aug 11, 2016 <p>Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and ForSight VISION5, a privately held, clinical-stage biotechnology company focused on eye …See details»
ForSight VISION5 - VentureRadar
Similar Companies: Website: http://forsightlabs.com/ ForSight VISION5, Inc. (www.forsightv5.com), was founded in January of 2011 as the fifth company to emerge from ...See details»
ForSight VISION5 Inc - Company Profile and News
Company profile page for ForSight VISION5 Inc including stock price, company news, executives, board members, and contact informationSee details»
Forsight VISION5 - Products, Competitors, Financials, Employees ...
ForSight VISION5 was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs (www.forsightlabs.com). Use the CB Insights Platform to …See details»
ForSight VISION5, Inc. - VentureRadar
ForSight VISION5, Inc. VentureRadar profile. Find out more about ForSight VISION5, Inc., Pharma.See details»
ForSight VISION5 - H.I.G. Capital Portfolio Company
ForSight VISION5 develops non-invasive products that replace eye drops and provide sustained therapy for major anterior segment eye diseases. ForSight VISION5, Inc. was founded in …See details»
ForSight VISION5 - Owler
ForSight VISION5’s Profile, Revenue and Employees. ForSight VISION5 researches, develops and commercializes non-invasive products for the treatment of glaucoma and dry eye …See details»
Allergan to acquire Forsight Vision5 for $95 million
Aug 16, 2016 Allergan says it plans to buy the Silicon Valley developer of an innovative alternative to glaucoma eye drops, a sustained-release bimatoprost insert.. The insert is a …See details»
FORSIGHT VISION, LTD. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FORSIGHT VISION, LTD. of Long Grove, IL. Get the latest business insights from Dun & Bradstreet.See details»
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15, 2016 The deal will see Allergan (AGN) making an upfront payment of $95 million as well as a launch milestone payment related to ForSight's lead development program.See details»
Allergan picks up novel glaucoma device in $95M ForSight buy
Aug 11, 2016 “If approved, this technology could provide an important advance to address the significant challenges of patient compliance and adherence in glaucoma," said Allergan R&D …See details»
Forsight VISION5 | Portfolio - Versant Ventures
ForSight VISION5 is focused on developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy.See details»
forsightvision5.com - News Center | AbbVie News Cent.
Forsightvision5.com. AbbVie Inc. Newsroom - the official site for press releases, photos, video, audio, pr contact information, presskits and more.See details»
Forsight Vision Care - Crunchbase Company Profile & Funding
Organization. Forsight Vision Care . Connect to CRM . Save . Summary. People. Technology. Signals & News. ... Contact Email [email protected]; Phone Number +1 224 524 …See details»